Bergen Brunswig Is Planning Securities Sale

Bergen Brunswig Corp. said it filed plans with regulators to sell up to $400 million worth of securities. The drug supplier intends to sell debt securities, preferred stock, common stock or warrants to purchase stock from time to time. Proceeds will be used for general corporate purposes, including repayment of debt, possible acquisitions or working capital needs.